文献速递心血管MR

基于心脏磁共振的慢性缺血性左心室室壁瘤患者不良结局风险分层

CMR-Based Risk Stratification for Adverse Outcomes in Chronic Ischemic Left Ventricular Aneurysm Patients.
PubMed 文献 · Acad Radiol · 2025-06-18

研究纳入243例慢性缺血性左心室室壁瘤患者,基于临床资料与心脏磁共振特征构建主要不良心血管事件预测模型。中位随访2.6年期间82例(33.7%)发生主要不良心血管事件,独立预测因子包括年龄、纽约心脏协会心功能分级、室壁瘤最大横径、晚期钆增强范围和左心房增压泵应变。纳入左心房增压泵应变后模型区分度与重分类均显著改善。

要点

  • 左心房增压泵应变是独立保护性预测因子(HR 0.84,p<0.001)。
  • 室壁瘤最大横径与晚期钆增强范围均为独立预测因子(HR 1.02、1.03)。
  • 纳入左心房增压泵应变使模型C指数提升0.037(p<0.001)。

核心结论

  • 整合临床与心脏磁共振生物标志物(尤其左心房增压泵应变)可有效预测慢性缺血性左心室室壁瘤患者的不良结局。

研究设计与样本

  • 从1825例心肌梗死患者中纳入243例慢性缺血性左心室室壁瘤患者,采用单因素Cox回归和LASSO算法筛选预测因子,多因素Cox回归确定独立预测因子并构建列线图。

关键影像表现/征象

  • 晚期钆增强范围是主要不良心血管事件的独立预测因子(HR 1.03,p=0.020)。
  • 室壁瘤最大横径是主要不良心血管事件的独立预测因子(HR 1.02,p=0.020)。
  • 左心房增压泵应变为独立预测因子(HR 0.84,p<0.001)。

诊断标准与关键数值

  • 中位随访2.6年,82例(33.7%)患者发生主要不良心血管事件。
  • 年龄HR 1.03(p=0.014)、纽约心脏协会心功能分级HR 1.04(p=0.001)为独立预测因子。
  • 纳入左心房增压泵应变后模型区分度改善ΔC-index=0.037(p<0.001)。
  • 重分类改善:integrated discrimination improvement=0.100、net reclassification improvement=0.357(均p<0.001)。

临床应用与阅片要点

  • 作者认为整合临床与心脏磁共振生物标志物(尤其左心房增压泵应变)可有效预测慢性缺血性左心室室壁瘤患者的不良结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Chronic ischemic left ventricular aneurysm (LVA) indicates poor prognosis, yet clinically effective predictive tools for risk stratification are lacking. This study aims to explore the independent risk factors for predicting major adverse cardiovascular events (MACEs) in patients with chronic ischemic LVA, based on clinical data and cardiac magnetic resonance (CMR) imaging features.

METHODS: From 1825 patients with myocardial infarction, a total of 243 patients with chronic ischemic LVA were enrolled in this study. Predictors of MACEs were identified using univariate Cox regression and the least absolute shrinkage and selection operator (LASSO) algorithm. Multivariate Cox regression analysis was performed to identify independent predictors and construct a nomogram.

RESULTS: Over a median follow-up period of 2.6 years, 82 (33.7%) patients experienced MACEs. Independent predictors incorporated into the predictive model were age [hazard ratio (HR) 1.03, p=0.014], New York Heart Association class (HR 1.04, p=0.001), LVA maximum transverse diameter (HR 1.02, p=0.020), extent of late gadolinium enhancement (HR 1.03, p=0.020), and left atrial booster strain (LA-εa; HR 0.84, p<0.001). Incorporating LA-εa significantly improved model discrimination (ΔC-index = 0.037, p<0.001) and reclassification (integrated discrimination improvement=0.100, net reclassification improvement=0.357, all p<0.001).

CONCLUSION: The integration of clinical and CMR biomarkers, particularly LA-εa, is effective for predicting adverse outcomes in patients with chronic ischemic LVA.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Bo K, Wang H, Zhang F, et al. CMR-Based Risk Stratification for Adverse Outcomes in Chronic Ischemic Left Ventricular Aneurysm Patients. Acad Radiol. 2025. PMID: 40537380. doi:10.1016/j.acra.2025.05.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。